Admedus Buy Hold or Sell Recommendation

AMEUF -- USA Stock  

USD 0.07  0.015  30.00%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Admedus Limited is 'Strong Sell'. Macroaxis provides Admedus buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Admedus positions. The advice algorithm takes into account all of Admedus Limited available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Admedus buy-and-hold prospective. Check also Admedus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell AdmedusBuy Admedus
Strong Sell

Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon Admedus Limited has a mean deviation of 20.33, semi deviation of 21.03, standard deviation of 53.28, variance of 2839.29, downside variance of 2536.53 and semi variance of 442.21
We provide buy or sell advice to complement the prevailing expert consensus on Admedus Limited. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Admedus is not overpriced, please confirm all Admedus Limited fundamentals including its Debt to Equity, Total Asset and the relationship between Net Income and Earnings Per Share . As Admedus Limited appears to be a penny stock we also recommend to validate its Price to Book numbers.

Admedus Returns Distribution Density

Mean Return5.26Value At Risk40
Potential Upside30.95Standard Deviation53.25
 Return Density 
      Distribution 

Admedus Greeks

α
Alpha over DOW
=3.07
β
Beta against DOW=11.43
σ
Overall volatility
=53.78
Ir
Information ratio =0.10

Admedus Volatility Alert

Admedus Limited is showing large volatility of returns over the selected time horizon. We encourage all investors to investigate this asset further to make sure related market timing strategies are aligned with all the expectations about Admedus implied risk. Admedus Limited is a penny stock. Although Admedus may be in fact a good investment, many penny stocks are subject to artificial stock hype. Make sure you completely understand upside potential and downside risk of investing in Admedus Limited. We encourage investors to look for the signals such us message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
    
 Better Than Average     
    
 Worse Than Average Compare Admedus to competition

Admedus Fundamental Vs Peers

FundamentalsAdmedusPeer Average
Return On Equity(65.41)% (15.17)%
Return On Asset(35.80)% (15.64)%
Profit Margin(68.01)% (5.50)%
Operating Margin(83.35)% (10.91)%
Current Valuation18.91M152.14B
Shares Outstanding284M1.43B
Price to Earning(3.20)X40.69X
Price to Book2.41X14.44X
Price to Sales0.97X17.81X
Revenue15.81M9.85B
Gross Profit10.29M21.75B
EBITDA(11.83M)1.41B
Net Income(10.75M)517.71M
Cash and Equivalents3.27M3.89B
Cash per Share0.01X5.17X
Total Debt3.29M7.36B
Debt to Equity40.60% 0.72%
Current Ratio1.58X3.30X
Book Value Per Share0.03X13.64X
Cash Flow from Operations(7.18M)1.25B
Earnings Per Share(0.041)X2.30X
Number of Employees1210.67K
Beta-1.30.34
Market Capitalization15.29M29.78B
Total Asset27M126.86B
Retained Earnings(69M)38.24B
Working Capital13M3.58B
Current Asset17M36.8B
Current Liabilities4M33.34B
Z Score-0.4708.73

Admedus Alerts

Trading Alerts and Improvement Suggestions

Admedus Limited appears to be very risky and stock price may revert if volatility continues
Admedus Limited has some characteristics of a very speculative penny stock
Admedus Limited has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 15.81M. Net Loss for the year was (10.75M) with profit before overhead, payroll, taxes, and interest of 10.29M.
ADMEDUS has accumulated about 3.27M in cash with (7.18M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check also Admedus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Search macroaxis.com